Medline Inc. (MDLN) — Financial statements
Income statement, balance sheet, and cash flow for Medline Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue & Gross Profit | |||||
| Revenue | 28,432↑11.5% | 25,507↑9.8% | 23,231↑8.3% | 21,448 | |
| Cost of Revenue | 20,914↑8.8% | 19,216↑6.7% | 18,008↑6.6% | 16,891 | |
| Gross Profit | 7,518↑19.5% | 6,291↑20.4% | 5,223↑14.6% | 4,557 | |
| Operating Expenses | |||||
| R&D Expenses | 0.00↓100.0% | 67↑11.7% | 60↑3.4% | 58 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 4,524↑12.0% | 4,041↑6.1% | 3,807↑5.2% | 3,618 | |
| Other Expenses | 782↑1961.9% | -42↑52.3% | -88↓900.0% | 11 | |
| Operating Expenses | 5,306↑30.5% | 4,066↑7.6% | 3,779↑2.5% | 3,687 | |
| Total Costs & Expenses | 26,220↑12.6% | 23,282↑6.9% | 21,787↑5.9% | 20,578 | |
| Operating Results | |||||
| Operating Income | 2,212↓0.6% | 2,225↑54.1% | 1,444↑66.0% | 870 | |
| Depreciation & Amortization | 704↓27.9% | 977↑2.7% | 951↑1.9% | 933 | |
| EBITDA | 2,916↓17.4% | 3,532↑36.4% | 2,590↑39.7% | 1,854 | |
| EBIT | 2,212↓13.4% | 2,555↑55.9% | 1,639↑78.0% | 921 | |
| Interest & Other Income | |||||
| Net Interest Income | -812↑21.1% | -1,029↑9.6% | -1,138↓28.7% | -884 | |
| Interest Income | 0.00↓100.0% | 280↑18.1% | 237↑777.8% | 27 | |
| Interest Expense | 0.00↓100.0% | 1,309↓4.8% | 1,375↑50.9% | 911 | |
| Non-Operating Income | 0.00↑100.0% | -330↓69.2% | -195↓282.4% | -51 | |
| Other Income / Expenses | -964↑1.5% | -979↑17.0% | -1,180↓37.2% | -860 | |
| Income Before Tax | 1,248↑0.2% | 1,246↑372.0% | 264↑2540.0% | 10 | |
| Income Tax Expense | 91↑97.8% | 46↑53.3% | 30↓14.3% | 35 | |
| Net Income & EPS | |||||
| Net Income from Continuing Operations | 1,157↓3.6% | 1,200↑412.8% | 234↑1036.0% | -25 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 1,159↓3.4% | 1,200↑412.8% | 234↑1036.0% | -25 | |
| Bottom-Line Net Income | 1,159↓3.4% | 1,200↑412.8% | 234↑1036.0% | -25 | |
| EPS (Basic) | 1.43↓5.9% | 1.52↑406.7% | 0.30↑1043.4% | -0.03 | |
| EPS (Diluted) | 1.43↓5.9% | 1.52↑406.7% | 0.30↑1043.4% | -0.03 | |
| Weighted Average Shares | 812↑3.2% | 787↑0.0% | 787↑0.0% | 787 | |
| Weighted Average Diluted Shares | 812↑3.2% | 787↑0.0% | 787↑0.0% | 787 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.